Author:
Cornejo-Juárez Patricia,Suárez-Cuenca Juan Antonio,Volkow-Fernández Patricia,Silva-Sánchez Jesús,Barrios-Camacho Humberto,Nájera-León Esmeralda,Velázquez-Acosta Consuelo,Vilar-Compte Diana
Publisher
Springer Science and Business Media LLC
Reference34 articles.
1. Arnan M, Gudiol C, Calatayud L, Liñares J, Dominguez MA, Batlle M et al (2011) Risk factors for, and clinical relevance of, faecal extended-spectrum β-lactamase producing Escherichia coli (ESBL-EC) carriage in neutropenic patients with haematological malignancies. Eur J Clin Microbiol Dis 30:355–360. doi: 10.1007/s10096-010-1093-x
2. Yu WL, Chuang YC, Walther-Rasmussen J (2006) Extended-spectrum beta-lactamases in Taiwan: epidemiology, detection, treatment and infection control. J Microbiol Immunol Infect 39:264–277
3. Ben-Ami R, Rodríguez-Baño J, Arslan H, Pitout JD, Quentin C, Calbo ES et al (2009) A multinational survey of risk factors for infection with extended-spectrum beta-lactamase-producing enterobacteriaceae in nonhospitalized patients. Clin Infect Dis 49:682–690. doi: 10.1086/604713
4. Melzer M, Petersen I (2007) Mortality following bacteraemic infection caused by extended spectrum beta-lactamase (ESBL) producing Escherichia coli compared to non-ESBL producing E. coli. J Infection 55:254–259
5. Clinical and Laboratory Standards Institute (2011) Performance standards for antimicrobial susceptibility testing. 21st Informational Supplement, M-100-S21. Wayne, PA, USA: CLSI
Cited by
67 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献